CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 186 filers reported holding CHEMOCENTRYX INC in Q2 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $405,000 | +108.8% | 7,831 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $194,000 | -2.5% | 7,831 | -1.1% | 0.00% | 0.0% |
| Q1 2022 | $199,000 | -42.7% | 7,919 | -16.9% | 0.00% | -50.0% |
| Q4 2021 | $347,000 | +250.5% | 9,534 | +64.4% | 0.00% | +100.0% |
| Q3 2021 | $99,000 | +26.9% | 5,800 | 0.0% | 0.00% | – |
| Q2 2021 | $78,000 | -73.7% | 5,800 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $297,000 | -26.8% | 5,800 | -11.6% | 0.00% | 0.0% |
| Q4 2020 | $406,000 | +68.5% | 6,560 | +49.2% | 0.00% | 0.0% |
| Q3 2020 | $241,000 | -4.7% | 4,398 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $253,000 | +143.3% | 4,398 | +70.1% | 0.00% | +100.0% |
| Q1 2020 | $104,000 | +2.0% | 2,586 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $102,000 | +1175.0% | 2,586 | +131.1% | 0.00% | – |
| Q3 2019 | $8,000 | -20.0% | 1,119 | 0.0% | 0.00% | – |
| Q2 2019 | $10,000 | – | 1,119 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |